Gluten-sensitive hypertransaminasemia in celiac disease: An infrequent and often subclinical finding

American Journal of Gastroenterology

Volumn 106, Issue 9, 2011, Pages 1689-1696

  Korpimäki, Satu ^a   Kaukinen, Katri ^b   Collin, Pekka ^b   Haapala, Anna Maija ^b   Holm, Päivi ^b   Laurila, Kaija ^a   Kurppa, Kalle ^a   Saavalainen, Päivi ^c   Haimila, Katri ^d   Partanen, Jukka ^d   Mäki, Markku ^a   Lähdeaho, Marja Leena ^a  

^a TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^b TAMPERE UNIVERSITY HOSPITAL   (Finland)

^c UNIVERSITY OF HELSINKI   (Finland)

^d FINNISH RED CROSS BLOOD SERVICE   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; HLA ANTIGEN;

ABDOMINAL PAIN; ADOLESCENT; ADULT; AGED; ARTHRALGIA; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BLOOD SAMPLING; BODY MASS; CELIAC DISEASE; CLINICAL EVALUATION; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIARRHEA; DISEASE SEVERITY; FEMALE; FLATULENCE; GLUTEN FREE DIET; HLA TYPING; HUMAN; HYPERTRANSAMINASEMIA; INTESTINE BIOPSY; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; PATIENT MONITORING; PRIORITY JOURNAL; PROSPECTIVE STUDY; REMISSION; SCREENING;

EID: 85027941772     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2011.134     Document Type: Article

References (40)

1. Lindfors K, M ä ki M, Kaukinen K. Transglutaminase 2-targeted autoantibodies in celiac disease: pathogenic players in addition to diagnostic tools? Autoimmun Rev 2010; 9: 744-9.
2. Volta U, De Franceschi L, Lari F et al. Coeliac disease hidden by cryptogenic hypertransaminasemia. Lancet 1998; 352: 26-9. (Pubitemid 28306562)
3. Bardella MT, Fraquelli M, Quatrini M et al. Prevalence of hypertransaminasemia in adult celiac patients and effect of gluten-free diet. Hepatology 1995; 22: 833-6.
4. Rubio-Tapia A, Murray JA. The liver in celiac disease. Hepatology 2007; 46: 1650-8. (Pubitemid 350155546)
5. Rubio-Tapia A, Abdulkarim AS, Wiesner RH et al. Celiac disease autoantibodies in severe autoimmune liver disease and the effect of liver transplantation. Liver Int 2008; 28: 467-76. (Pubitemid 351411132)
6. Ludvigsson JF, Elfström P, Broom é U et al. Celiac disease and risk of liver disease: a general population-based study. Clin Gastroenterol Hepatol 2007; 5: 63-9.
7. Farre C, Esteve M, Curcoy A et al. Hypertransaminasemia in pediatric celiac disease patients and its prevalence as a diagnostic clue. Am J Gastroenterol 2002; 97: 3176-81. (Pubitemid 35424593)
8. Jacobsen MB, Fausa O, Elgjo K et al. Hepatic lesions in adult coeliac disease. Scand J Gastroenterol 1990; 25: 656-62. (Pubitemid 20214562)
9. Hagander B, Berg N, Brandt L et al. Hepatic injury in adult coeliac disease. Lancet 1977; 1: 270-2. (Pubitemid 8152956)
10. Novacek G, Miehsler W, Wrba F et al. Prevalence and clinical importance of hypertransaminasaemia in coeliac disease. Eur J Gastroenterol Hepatol 1999; 11: 283-8. (Pubitemid 29286682)
11. Bardella MT, Vecchi M, Conte D et al. Chronic unexplained hypertrans aminasemia may be caused by occult celiac disease. Hepatology 1999; 29: 654-7. (Pubitemid 29109576)
12. Volta U, De Franceschi L, Molinaro N et al. Frequency and significance of anti-gliadin and anti-endomysial antibodies in autoimmune hepatitis. Dig Dis Sci 1998; 43: 2190-5. (Pubitemid 28487246)
13. Volta U, Rodrigo L, Granito A et al. Celiac disease in autoimmune cholestatic liver disorders. Am J Gastroenterol 2002; 97: 2609-13.
14. Lawson A, West J, Aithal GP et al. Autoimmune cholestatic liver disease in people with coeliac disease: a population-based study of their association. Aliment Pharmacol Ther 2005; 21: 401-5. (Pubitemid 40313942)
15. Caprai S, Vajro P, Ventura A et al. SSGfALDiC. Autoimmune liver disease associated with celiac disease in childhood: a multicenter study. Clin Gastroenterol Hepatol 2008; 6: 803-6.
16. Kaukinen K, Halme L, Collin P et al. Celiac disease in patients with severe liver diseases: gluten-free diet may reverse hepatic failure. Gastroenterology 2002; 122: 881-8. (Pubitemid 34267270)
17. Pietzak MM. Follow-up of patients with celiac disease: achieving compliance with treatment. Gastroenterology 2005; 128: S135-41. (Pubitemid 40460834)
18. Haines ML, Anderson RP, Gibson PR. Systematic review: the evidence base for long-term management of coeliac disease. Aliment Pharmacol Ther 2008; 28: 1042-66.
19. Lohi S, Mustalahti K, Kaukinen K et al. Increasing prevalence of coeliac disease over time. Aliment Pharmacol Ther 2007; 26: 1217-25. (Pubitemid 47620425)
20. Fasano A, Berti I, Gerarduzzi T et al. Prevalence of celiac disease in at-risk and not-at-risk groups in the United States: a large multicenter study. Arch Intern Med 2003; 163: 286-92. (Pubitemid 36183856)
21. Virta L, Kaukinen K, Collin P. Incidence and prevalence of diagnosed coeliac disease in Finland: results of effective case finding in adults. Scand J Gastroenterol 2009; 44: 933-8.
22. Viljamaa M, Kaukinen K, Pukkala E et al. Malignancies and mortality in patients with coealic disease and dermatitis herpetiformis: 30-year population-based study. Dig Liver Dis 2006; 38: 374-80. (Pubitemid 44356222)
23. Kurppa K, Collin P, Viljamaa M et al. Diagnosing mild enteropathy celiac disease: a randomized, controlled clinical study. Gastroenterology 2009; 136: 816-23.
24. Sulkanen S, Halttunen T, Laurila K et al. Tissue transglutaminase autoantibody enzyme-linked immunosorbent assay in detecting celiac disease. Gastroenterology 1998; 115: 1322-8. (Pubitemid 28545980)
25. J ä rvinen TT, Kaukinen K, Laurila K et al. Intraepithelial lymphocytes in celiac disease. Am J Gastroenterol 2003; 98: 1332-7. (Pubitemid 36741531)
26. Koskinen L, Romanos J, Kaukinen K et al. Cost-effective HLA typing with tagging SNPs predicts celiac disease risk haplotypes in the Finnish, Hungarian, and Italian populations. Immunogenetics 2009; 61: 247-56.
27. Clark JM, Brancati FL, Diehl AM. The prevalence and etiology of elevated aminotransferase levels in the United States. Am J Gastroenterol 2003; 98: 960-7. (Pubitemid 36733754)
28. Adams LA, Knuiman MW, Divitini ML et al. Body mass index is a stronger predictor of alanine aminotransaminase levels than alcohol consumption. J Gastroenterol Hepatol 2008; 23: 1089-93. (Pubitemid 352019382)
29. Pendino GM, Mariano AM, Surace race P et al. Prevalence and etiology of altered liver tests: a population-based survey in a Mediterranean town. Hepatology 2005; 41: 1151-9. (Pubitemid 40593924)
30. Karell K, Louka AS, Moodie SJ et al. HLA types in celiac disease patients not carrying the DQA1*05-DQB1*02 (DQ2) heterodimer: results from the European genetics cluster on celiac disease. Hum Immunol 2003; 64: 469-77. (Pubitemid 36373778)
31. Miele L, Valenza V, La Torre G et al. Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease. Hepatology 2009; 49: 1877-87.
32. Smecuol E, Bai JC, Vazquez H et al. Gastrointestinal permeability in celiac disease. Gastroenterology 1997; 112: 1129-36. (Pubitemid 27157523)
33. Ciccocioppo R, Finamore A, Ara C et al. Altered expression, localization, and phosphorylation of epithelial junctional proteins in celiac disease. Am J Clin Pathol 2006; 125: 502-11.
34. Etukudo MH, Agbedana EO, Akinyinka OO et al. Plasma electrolytes, total cholesterol, liver enzymes, and selected antioxidant status in protein energy malnutrition. Afr J Med Med Sci 1999; 28: 81-5.
35. Aeschlimann D, Paulsson M. Cross-linking of laminin-nidogen complexes by tissue transglutaminase. J Biol Chem 1991; 266: 15308-17.
36. Jabri B, Sollid LM. Tissue-mediated control of immunopathology in coeliac disease. Nat Rev Immunol 2009; 9: 858-70.
37. Dieterich W, Ehnis T, Bauer M et al. Identification of tissue transglutaminase as the autoantigen of celiac disease. Nat Med 1997; 3: 797-801. (Pubitemid 27298728)
38. Korponay-Szabo IR, Halttunen T, Szalai Z et al. In vivo targeting of intestinal and extraintestinal transglutaminase 2 by coeliac autoantibodies. Gut 2004; 53: 641-8. (Pubitemid 38561440)
39. Hadjivassiliou M, M ä ki M, Sanders D et al. Autoantibody targeting of brain and intestinal transglutaminase in gluten ataxia. Neurology 2006; 66: 373-7. (Pubitemid 43739939)
40. Kulkarni BR, Brancati FL, Seeff LB et al. A systemic review of the stability of serum alanine aminotransferase and aspartate aminotransferase in storage conditions. Hepatology 2004; 40 (Suppl 1): 715A.